Inflarx N.V. (($IFRX)) announced an update on their ongoing clinical study. Study Overview: The JUST BREATHE study, ...

We recently published a list of the 12 Biotech Stocks with the Biggest Upside Potential. In this article, we are going to take a look at where Merus N.V. (NASDAQ:MRUS) stands against other biotech ...

As major U.S. stock indexes continue to set fresh records, investors are closely watching the Federal Reserve's latest moves and the potential impact on market trends. In this context, penny ...

I’m a bit behind and therefore am not part of the slew of commentary that flowed from the Supreme Court’s decision in Amgen Inc. v. Sanofi, 143 S. Ct. 1243, 1248 (2023), addressing Amgen’s claims to ...

The Boston-based biotech is axing Phase II plans for its only clinical-stage asset, in a bid to maximise shareholder value.

Secarna Pharma inks agreement with Scenic Biotech to discover and co-develop disease-modifying oligonucleotide therapy against a novel drug target: Munich, Germany Saturday, Octob ...

Is no one safe from the FTC? Has Pfizer bottomed out? And is biotech finally back? We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. First, we delve into the fallout ...

The comprehensive report from the bipartisan National Security Commission on Emerging Biotechnology (NSCEB) delivers a “sobering, even frightening,” conclusion: that China is quickly ascending to ...

Greenberg Traurig filed a trademark infringement lawsuit Monday in New Jersey District Court on behalf of dental implant manufacturer MegaGen Implant Co. Ltd. The suit accuses Biotech Dental LLC, ...

VEP Biotech sued Quadrant Biosciences for contact breach over Quadrant's failure to pay, despite ample notice, the principal amount of a $5 million convertible note (Note), plus interest, after the ...

Doha's healthcare expenditure is slated to touch $13bn by 2030, showing a 14% compound annual growth rate (CAGR) and ...